
Monica E. Millner
Examiner (ID: 13456, Phone: (571)270-7507 , Office: P/3632 )
| Most Active Art Unit | 3632 |
| Art Unit(s) | 3632, 3627, 3508 |
| Total Applications | 1500 |
| Issued Applications | 1152 |
| Pending Applications | 94 |
| Abandoned Applications | 283 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6692222
[patent_doc_number] => 20030039654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein'
[patent_app_type] => new
[patent_app_number] => 09/843221
[patent_app_country] => US
[patent_app_date] => 2001-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22417
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20030039654.pdf
[firstpage_image] =>[orig_patent_app_number] => 09843221
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/843221 | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein | Apr 25, 2001 | Issued |
Array
(
[id] => 6597989
[patent_doc_number] => 20020042372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'Stanniocalcin polynucleotides, polypeptides, and methods based thereon'
[patent_app_type] => new
[patent_app_number] => 09/840989
[patent_app_country] => US
[patent_app_date] => 2001-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 88407
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042372.pdf
[firstpage_image] =>[orig_patent_app_number] => 09840989
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/840989 | Stanniocalcin polynucleotides, polypeptides, and methods based thereon | Apr 24, 2001 | Abandoned |
Array
(
[id] => 6898791
[patent_doc_number] => 20010046956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-29
[patent_title] => 'Methods of treating obesity using a neurotensin receptor ligand'
[patent_app_type] => new
[patent_app_number] => 09/841276
[patent_app_country] => US
[patent_app_date] => 2001-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20481
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20010046956.pdf
[firstpage_image] =>[orig_patent_app_number] => 09841276
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/841276 | Methods of treating obesity using a neurotensin receptor ligand | Apr 23, 2001 | Issued |
Array
(
[id] => 6814058
[patent_doc_number] => 20030073608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Process for treating disease'
[patent_app_type] => new
[patent_app_number] => 09/832015
[patent_app_country] => US
[patent_app_date] => 2001-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8017
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073608.pdf
[firstpage_image] =>[orig_patent_app_number] => 09832015
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/832015 | Process for treating disease | Apr 9, 2001 | Abandoned |
Array
(
[id] => 1164044
[patent_doc_number] => 06759386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-06
[patent_title] => 'Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease'
[patent_app_type] => B2
[patent_app_number] => 09/828330
[patent_app_country] => US
[patent_app_date] => 2001-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26450
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759386.pdf
[firstpage_image] =>[orig_patent_app_number] => 09828330
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/828330 | Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease | Apr 5, 2001 | Issued |
Array
(
[id] => 6618454
[patent_doc_number] => 20020086015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Compositions and methods for promoting nerve regeneration'
[patent_app_type] => new
[patent_app_number] => 09/825243
[patent_app_country] => US
[patent_app_date] => 2001-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10564
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086015.pdf
[firstpage_image] =>[orig_patent_app_number] => 09825243
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/825243 | Methods of using geldanamycin and FK506 to treat peripheral nerve damage | Apr 1, 2001 | Issued |
Array
(
[id] => 6500625
[patent_doc_number] => 20020025540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Isolation of functionally active gamma- secretase protein complex and methods for detection of activity and Inhibitors thereof'
[patent_app_type] => new
[patent_app_number] => 09/823153
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 22201
[patent_no_of_claims] => 97
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025540.pdf
[firstpage_image] =>[orig_patent_app_number] => 09823153
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/823153 | Methods for detection of gamma-secretase activity and identification of inhibitors thereof | Mar 29, 2001 | Issued |
| 09/762596 | USE OF INSULIN AND BDNF TO CONTROL BLOOD GLUCOSE LEVELS | Mar 19, 2001 | Abandoned |
Array
(
[id] => 5875075
[patent_doc_number] => 20020049303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Catalytically active recombinant memapsin and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 09/796264
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19722
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049303.pdf
[firstpage_image] =>[orig_patent_app_number] => 09796264
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/796264 | Catalytically active recombinant memapsin and methods of use thereof | Feb 27, 2001 | Abandoned |
Array
(
[id] => 6243025
[patent_doc_number] => 20020045577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Human schizophrenia gene'
[patent_app_type] => new
[patent_app_number] => 09/795668
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23792
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045577.pdf
[firstpage_image] =>[orig_patent_app_number] => 09795668
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/795668 | Human schizophrenia gene | Feb 27, 2001 | Abandoned |
Array
(
[id] => 6307833
[patent_doc_number] => 20020094954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Human schizophrenia gene'
[patent_app_type] => new
[patent_app_number] => 09/795686
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22826
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094954.pdf
[firstpage_image] =>[orig_patent_app_number] => 09795686
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/795686 | Human schizophrenia gene | Feb 27, 2001 | Abandoned |
Array
(
[id] => 6689048
[patent_doc_number] => 20030032773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression'
[patent_app_type] => new
[patent_app_number] => 09/791389
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 55635
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032773.pdf
[firstpage_image] =>[orig_patent_app_number] => 09791389
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/791389 | Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression | Feb 22, 2001 | Abandoned |
Array
(
[id] => 1227993
[patent_doc_number] => 06696273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-24
[patent_title] => 'FEBP1 Protein: vector, host cells and method for making FEBP1 protein'
[patent_app_type] => B2
[patent_app_number] => 09/780996
[patent_app_country] => US
[patent_app_date] => 2001-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9232
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/696/06696273.pdf
[firstpage_image] =>[orig_patent_app_number] => 09780996
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/780996 | FEBP1 Protein: vector, host cells and method for making FEBP1 protein | Feb 8, 2001 | Issued |
| 09/701029 | Novel G-protein coupled receptor | Feb 6, 2001 | Abandoned |
Array
(
[id] => 7182857
[patent_doc_number] => 20040203000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'CELL-SIGNALING ASSAYS'
[patent_app_type] => new
[patent_app_number] => 09/768661
[patent_app_country] => US
[patent_app_date] => 2001-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11939
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20040203000.pdf
[firstpage_image] =>[orig_patent_app_number] => 09768661
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/768661 | Cell-signaling assays | Jan 22, 2001 | Issued |
Array
(
[id] => 6499963
[patent_doc_number] => 20020025508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Process for finding a protease inhibitor'
[patent_app_type] => new
[patent_app_number] => 09/755417
[patent_app_country] => US
[patent_app_date] => 2001-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7118
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025508.pdf
[firstpage_image] =>[orig_patent_app_number] => 09755417
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/755417 | Process for finding a protease inhibitor | Jan 4, 2001 | Abandoned |
Array
(
[id] => 971861
[patent_doc_number] => 06936246
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-30
[patent_title] => 'Passive immunization of ASCR for prion disorders'
[patent_app_type] => utility
[patent_app_number] => 09/724570
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 42086
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/936/06936246.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724570
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724570 | Passive immunization of ASCR for prion disorders | Nov 27, 2000 | Issued |
Array
(
[id] => 1175237
[patent_doc_number] => 06743427
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-01
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => B1
[patent_app_number] => 09/724961
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 0
[patent_no_of_words] => 43821
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/743/06743427.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724961
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724961 | Prevention and treatment of amyloidogenic disease | Nov 27, 2000 | Issued |
Array
(
[id] => 1005095
[patent_doc_number] => 06905686
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-14
[patent_title] => 'Active immunization for treatment of alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 09/724940
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 25
[patent_no_of_words] => 41004
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/905/06905686.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724940
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724940 | Active immunization for treatment of alzheimer's disease | Nov 27, 2000 | Issued |
Array
(
[id] => 1034227
[patent_doc_number] => 06875434
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-05
[patent_title] => 'Methods of treatment of Alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 09/724953
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 22
[patent_no_of_words] => 42117
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875434.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724953
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724953 | Methods of treatment of Alzheimer's disease | Nov 27, 2000 | Issued |